Relmada Therapeutics (RLMD) Non-Current Assets (2013 - 2026)
Relmada Therapeutics (RLMD) recorded Non-Current Assets of $19,500 in Q2 2026, down 11.3% from $21,975 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Non-Current Assets (2013 - 2026) Analysis & Trends
Starting with Q3 2013, Relmada Therapeutics' Non-Current Assets history includes 30 quarters.
- Annual Non-Current Assets has a five-year compound annual growth rate of -29.6% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $21,975 in FY2024 (-49.0%), $43,125 in FY2023 (+23.7%), $34,875 in FY2022 (+23.3%) and $28,293 in FY2021 (-74.9%).
- Quarterly Non-Current Assets has ranged from $16,095 in Q3 2022 to $53,625 in Q2 2024 over the past five years.
- On a year-over-year basis, Non-Current Assets has declined for three consecutive quarters, with an average decline of 30.6% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 196.5% in Q3 2023, against a decline of 74.9% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $19,500 (Q1 2026), $19,500 (Q4 2025) and $21,975 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Relmada Therapeutics | 404.28 Mn | 404.28 Mn | - | 19,500.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,500.00 |
| Mar 31, 2026 | 19,500.00 |
| Dec 31, 2025 | 19,500.00 |
| Sep 30, 2025 | 21,975.00 |
| Jun 30, 2025 | 21,975.00 |
| Mar 31, 2025 | 21,975.00 |
| Dec 31, 2024 | 21,975.00 |
| Sep 30, 2024 | 21,975.00 |
| Jun 30, 2024 | 53,625.00 |
| Mar 31, 2024 | 43,125.00 |
| Dec 31, 2023 | 43,125.00 |
| Sep 30, 2023 | 47,715.00 |
| Jun 30, 2023 | 34,590.00 |
| Mar 31, 2023 | 34,875.00 |
| Dec 31, 2022 | 34,875.00 |
| Sep 30, 2022 | 16,095.00 |
| Jun 30, 2022 | 35,238.00 |
| Mar 31, 2022 | 28,293.00 |
| Dec 31, 2021 | 28,293.00 |
| Sep 30, 2021 | 47,275.00 |
API Access
Relmada Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();